Publications

350 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

GVS advice avatrombopag (Doptelet®) for the treatment of thrombocytopenia

The National Health Care Institute has completed its assessment whether avatrombopag (Doptelet®) is interchangeable with a ...

Report | 08-06-2021

GVS advice Vocabria® and Rekambys® for the treatment of HIV-1 infection

The National Health Care Institute has completed its assessment whether the products Rekambys® and Vocabria® can be included in ...

Report | 08-06-2021

Package advice isatuximab (Sarclisa®) for the treatment of multiple myeloma

The National Health Care Institute has completed its assessment whether isatuximab (Sarclisa®) in combination with carfilzomib ...

Report | 25-05-2021

GVS advice ivacaftor (Kalydeco®) extension of further conditions

Zorginstituut Nederland carried out a review to extend the further conditions for reimbursement of ivacaftor (Kalydeco®). The ...

Report | 25-05-2021

GVS advice dapagliflozin (Forxiga®) extension of further condition

The National Health Care Institute has completed its assessment whether the further condition of dapagliflozin (Forxiga®) could ...

Report | 12-05-2021

Package advice pertuzumab and trastuzumab (Phesgo®) for the treatment of breast cancer

Zorginstituut Nederland has completed its assessment whether the fixed combined dose of pertuzumab and trastuzumab (Phesgo®) can ...

Report | 11-05-2021

Package advice onasemnogene abeparvovec (Zolgensma®) for the treatment of SMA

Zorginstituut Nederland has completed its assessment whether onasemnogene abeparvovec (Zolgensma®) for the treatment of patients ...

Report | 06-05-2021

GVS advice inclisiran (Leqvio®) for the treatment of hypercholesterolemia

The National Health Care Institute has completed its assessment whether inclisiran (Leqvio®) is interchangeable with a product ...

Report | 04-05-2021

Advice on the clustering of combination products and ghost clusters in GVS

The Minister of Medical Care has asked Zorginstituut Nederland questions about the clustering of two categories of medicinal ...

Report | 04-05-2021

GVS advice elexacaftor/tezacaftor/ivacaftor (Kaftrio®) in combination with ivacaftor (Kalydeco®)

The National Health Care Institute has completed its assessment whether elexacaftor/tezacaftor/ivacaftor (Kaftrio®) in ...

Report | 29-04-2021